vs
阿普塔集团（ATR）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
RXO, Inc.的季度营收约是阿普塔集团的1.5倍（$1.5B vs $962.7M），阿普塔集团净利率更高（7.7% vs -3.1%，领先10.9%），阿普塔集团同比增速更快（13.5% vs -11.9%），阿普塔集团自由现金流更多（$96.9M vs $-9.0M），过去两年RXO, Inc.的营收复合增速更高（26.8% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
ATR vs RXO — 直观对比
营收规模更大
RXO
是对方的1.5倍
$962.7M
营收增速更快
ATR
高出25.4%
-11.9%
净利率更高
ATR
高出10.9%
-3.1%
自由现金流更多
ATR
多$105.9M
$-9.0M
两年增速更快
RXO
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.5B |
| 净利润 | $74.3M | $-46.0M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | -2.9% |
| 净利率 | 7.7% | -3.1% |
| 营收同比 | 13.5% | -11.9% |
| 净利润同比 | -26.4% | -84.0% |
| 每股收益（稀释后） | $1.13 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRRXO
| Q4 25 | $962.7M | $1.5B | ||
| Q3 25 | $961.1M | $1.4B | ||
| Q2 25 | $966.0M | $1.4B | ||
| Q1 25 | $887.3M | $1.4B | ||
| Q4 24 | $848.1M | $1.7B | ||
| Q3 24 | $909.3M | $1.0B | ||
| Q2 24 | $910.1M | $930.0M | ||
| Q1 24 | $915.4M | $913.0M |
净利润ATRRXO
| Q4 25 | $74.3M | $-46.0M | ||
| Q3 25 | $127.9M | $-14.0M | ||
| Q2 25 | $111.7M | $-9.0M | ||
| Q1 25 | $78.8M | $-31.0M | ||
| Q4 24 | $100.9M | $-25.0M | ||
| Q3 24 | $100.0M | $-243.0M | ||
| Q2 24 | $90.5M | $-7.0M | ||
| Q1 24 | $83.1M | $-15.0M |
营业利润率ATRRXO
| Q4 25 | 11.0% | -2.9% | ||
| Q3 25 | 14.2% | -0.5% | ||
| Q2 25 | 14.9% | — | ||
| Q1 25 | 12.8% | -2.1% | ||
| Q4 24 | 14.2% | -1.4% | ||
| Q3 24 | 15.2% | -1.9% | ||
| Q2 24 | 13.8% | — | ||
| Q1 24 | 12.2% | -1.3% |
净利率ATRRXO
| Q4 25 | 7.7% | -3.1% | ||
| Q3 25 | 13.3% | -1.0% | ||
| Q2 25 | 11.6% | -0.6% | ||
| Q1 25 | 8.9% | -2.2% | ||
| Q4 24 | 11.9% | -1.5% | ||
| Q3 24 | 11.0% | -23.4% | ||
| Q2 24 | 9.9% | -0.8% | ||
| Q1 24 | 9.1% | -1.6% |
每股收益（稀释后）ATRRXO
| Q4 25 | $1.13 | $-0.28 | ||
| Q3 25 | $1.92 | $-0.08 | ||
| Q2 25 | $1.67 | $-0.05 | ||
| Q1 25 | $1.17 | $-0.18 | ||
| Q4 24 | $1.48 | $-0.17 | ||
| Q3 24 | $1.48 | $-1.81 | ||
| Q2 24 | $1.34 | $-0.06 | ||
| Q1 24 | $1.23 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $17.0M |
| 总债务越低越好 | $1.1B | $387.0M |
| 股东权益账面价值 | $2.7B | $1.5B |
| 总资产 | $5.3B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资ATRRXO
| Q4 25 | $409.5M | $17.0M | ||
| Q3 25 | $264.8M | $25.0M | ||
| Q2 25 | $169.8M | $18.0M | ||
| Q1 25 | $136.8M | $16.0M | ||
| Q4 24 | $226.2M | $35.0M | ||
| Q3 24 | $327.9M | $55.0M | ||
| Q2 24 | $223.9M | $7.0M | ||
| Q1 24 | $201.1M | $7.0M |
总债务ATRRXO
| Q4 25 | $1.1B | $387.0M | ||
| Q3 25 | $546.0M | $387.0M | ||
| Q2 25 | $535.1M | $387.0M | ||
| Q1 25 | $561.2M | $387.0M | ||
| Q4 24 | $688.1M | $351.0M | ||
| Q3 24 | $822.7M | $352.0M | ||
| Q2 24 | $681.5M | $370.0M | ||
| Q1 24 | $680.4M | $351.0M |
股东权益ATRRXO
| Q4 25 | $2.7B | $1.5B | ||
| Q3 25 | $2.8B | $1.6B | ||
| Q2 25 | $2.7B | $1.6B | ||
| Q1 25 | $2.5B | $1.6B | ||
| Q4 24 | $2.5B | $1.6B | ||
| Q3 24 | $2.5B | $1.7B | ||
| Q2 24 | $2.4B | $579.0M | ||
| Q1 24 | $2.3B | $582.0M |
总资产ATRRXO
| Q4 25 | $5.3B | $3.3B | ||
| Q3 25 | $5.1B | $3.2B | ||
| Q2 25 | $4.9B | $3.2B | ||
| Q1 25 | $4.5B | $3.3B | ||
| Q4 24 | $4.4B | $3.4B | ||
| Q3 24 | $4.6B | $3.4B | ||
| Q2 24 | $4.5B | $1.8B | ||
| Q1 24 | $4.4B | $1.8B |
负债/权益比ATRRXO
| Q4 25 | 0.43× | 0.25× | ||
| Q3 25 | 0.20× | 0.24× | ||
| Q2 25 | 0.20× | 0.24× | ||
| Q1 25 | 0.22× | 0.24× | ||
| Q4 24 | 0.28× | 0.22× | ||
| Q3 24 | 0.32× | 0.21× | ||
| Q2 24 | 0.28× | 0.64× | ||
| Q1 24 | 0.29× | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $-9.0M |
| 自由现金流率自由现金流/营收 | 10.1% | -0.6% |
| 资本支出强度资本支出/营收 | 9.0% | 1.1% |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流ATRRXO
| Q4 25 | $183.7M | $7.0M | ||
| Q3 25 | $177.6M | $23.0M | ||
| Q2 25 | $126.0M | $23.0M | ||
| Q1 25 | $82.7M | $-2.0M | ||
| Q4 24 | $178.2M | $-7.0M | ||
| Q3 24 | $229.3M | $-7.0M | ||
| Q2 24 | $143.6M | $-5.0M | ||
| Q1 24 | $92.3M | $7.0M |
自由现金流ATRRXO
| Q4 25 | $96.9M | $-9.0M | ||
| Q3 25 | $114.3M | $9.0M | ||
| Q2 25 | $62.5M | $9.0M | ||
| Q1 25 | $25.9M | $-17.0M | ||
| Q4 24 | $112.2M | $-19.0M | ||
| Q3 24 | $162.7M | $-18.0M | ||
| Q2 24 | $75.4M | $-16.0M | ||
| Q1 24 | $16.7M | $-4.0M |
自由现金流率ATRRXO
| Q4 25 | 10.1% | -0.6% | ||
| Q3 25 | 11.9% | 0.6% | ||
| Q2 25 | 6.5% | 0.6% | ||
| Q1 25 | 2.9% | -1.2% | ||
| Q4 24 | 13.2% | -1.1% | ||
| Q3 24 | 17.9% | -1.7% | ||
| Q2 24 | 8.3% | -1.7% | ||
| Q1 24 | 1.8% | -0.4% |
资本支出强度ATRRXO
| Q4 25 | 9.0% | 1.1% | ||
| Q3 25 | 6.6% | 1.0% | ||
| Q2 25 | 6.6% | 1.0% | ||
| Q1 25 | 6.4% | 1.0% | ||
| Q4 24 | 7.8% | 0.7% | ||
| Q3 24 | 7.3% | 1.1% | ||
| Q2 24 | 7.5% | 1.2% | ||
| Q1 24 | 8.3% | 1.2% |
现金转化率ATRRXO
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
